S&P 500

5.631,22

0,00%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ARDX

Ardelyx (ARDX)

Ardelyx Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

<< Previous 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
03/09/2019	14h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
03/09/2019	14h00	PR Newswire (US)	Ardelyx Announces Positive Results from the Pivotal Phase 3 AMPLIFY Study Evaluating Tenapanor in Dialysis Patients Who Have ...	NASDAQ:ARDX	Ardelyx Inc
02/09/2019	22h00	PR Newswire (US)	Ardelyx to Host Conference Call on September 3 to Review Results from the Pivotal Phase 3 AMPLIFY Study	NASDAQ:ARDX	Ardelyx Inc
23/08/2019	22h07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
23/08/2019	22h06	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:ARDX	Ardelyx Inc
20/08/2019	23h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	23h13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	22h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	22h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	22h35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	22h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	22h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
17/06/2019	22h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
14/06/2019	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
05/06/2019	13h59	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
30/05/2019	15h00	PR Newswire (US)	Ardelyx to Present at the Jefferies 2019 Global Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
07/05/2019	22h12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARDX	Ardelyx Inc
07/05/2019	22h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
07/05/2019	22h02	PR Newswire (US)	Ardelyx Reports First Quarter 2019 Financial Results and Recent Business Highlights	NASDAQ:ARDX	Ardelyx Inc
26/04/2019	22h17	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ARDX	Ardelyx Inc
26/04/2019	22h07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ARDX	Ardelyx Inc
10/04/2019	15h10	GlobeNewswire Inc.	Factors of Influence in 2019, Key Indicators and Opportunity within Cousins Properties, Versum Materials, Meritor, Ardelyx, M...	NASDAQ:ARDX	Ardelyx Inc
18/03/2019	22h11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
18/03/2019	22h09	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
18/03/2019	21h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
14/03/2019	22h00	PR Newswire (US)	Ardelyx Appoints Renowned Nephrologist, Geoffrey A. Block, M.D., to Its Board of Directors	NASDAQ:ARDX	Ardelyx Inc
08/03/2019	22h10	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ARDX	Ardelyx Inc
07/03/2019	23h00	PR Newswire (US)	Ardelyx Announces Peer-Reviewed Publication of Positive Phase 3 Results of Tenapanor for the Treatment of Hyperphosphatemia i...	NASDAQ:ARDX	Ardelyx Inc
06/03/2019	22h15	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ARDX	Ardelyx Inc
06/03/2019	22h10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc